GNPX News and Press, Genprex Inc. From 01/29/20

Study results show TUSC2 overexpression decreased thyroid cancer tumor metastasis and increased sensitivity to apoptosis by increasing SMAC/DIABLO and Cytochrome C protein levels Study highlights the possibility that TUSC2 may also be effective in thyroid cancer therapy and adds to...

Ocean Bio-Chem (NASDAQ: OBCI ) +80%  as its subsidiary Star brite announces registered EPA product kills the Coronavirus . More news on: Ocean Bio-Chem, Inc., Happiness Biotech Group Limited, Delphi Technologies PLC, Stocks on the move, , Read more ...

Capital raise follows recent Fast Track Designation by the FDA for Company’s Oncoprex™ imunogene therapy for NSCLC in combination therapy with AstraZeneca’s Tagrisso® Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX ), a ...

NeuroMetrix (NASDAQ: NURO )  -33%  on Q4 results . More news on: NeuroMetrix, Inc., NIO Limited, Genprex, Inc., Stocks on the move, , Read more ...

Genprex, Inc. ( GNPX ) has been on an outstanding two-day run since it announced that the FDA has granted Fast Track Designation for its Oncoprex immunogene therapy in combination with AstraZeneca's ( AZN ) Tagrisso for certain non-small cell lung cancer patients. The stock has risen from ...

Gainers: Trans World Entertainment TWMC  +260% . More news on: Kaleido BioSciences, Inc., SLM Corporation, Bat Group, Inc., , , Stocks on the move Read more ...

Genprex (NASDAQ: GNPX) , a clinical stage gene therapy company developing a new and potentially life-saving approach to treating some of the world’s most deadly cancers based upon a novel proprietary technology platform, today announced its entry into securities purchase agreements wit...

Genprex (NASDAQ: GNPX )  -37%  on pricing $8M stock offering. More news on: Genprex, Inc., Applied Genetic Technologies Corporation, Tetraphase Pharmaceuticals, Inc., Stocks on the move, , Read more ...

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX ), a clinical stage gene therapy company developing a new and potentially life-saving approach to treating some of the world’s most deadly cancers based upon a novel proprietary technology platform,...

Gainers: Neurotrope (NASDAQ: NTRP )  +126% . More news on: Neurotrope, Inc., Genprex, Inc., Trillium Therapeutics Inc., Stocks on the move, , Read more ...